Fox Run Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,782
Closed -$800K 1069
2025
Q3
$800K Buy
+10,782
New +$1.09M 0.12% 292
2023
Q4
Sell
-3,116
Closed -$618K 855
2023
Q3
$618K Sell
3,116
-86
-3% -$21.7K 0.18% 196
2023
Q2
$1.04M Buy
+3,202
New +$915K 0.29% 71
2021
Q1
Sell
-1,120
Closed -$211K 263
2020
Q4
$211K Buy
+1,120
New +$183K 0.43% 130
2020
Q3
Sell
-3,363
Closed -$293K 245
2020
Q2
$293K Buy
+3,363
New +$259K 0.39% 111

Other funds holding INSP

Fox Run Management's INSP Position: Q4 2025 in Review

Fox Run Management sold out of Inspire Medical Systems (INSP) in Q4 2025, closing a stake of 10,782 shares — an estimated $800K sold.

Fox Run Management first reported a position in INSP in Q2 2020 and held it in 5 quarters. The position peaked at $1.04M in Q2 2023. 342 funds tracked by Wall St. Rank hold INSP as of Q4 2025.

  • Fox Run Management reported no remaining Inspire Medical Systems position as of Q4 2025 after selling out during the quarter.
  • Fox Run Management sold 10,782 Inspire Medical Systems shares in Q4 2025, an estimated $800K.
  • Fox Run Management first reported a position in Inspire Medical Systems in Q2 2020 and held it in 5 quarters.
  • Fox Run Management's Inspire Medical Systems position peaked at $1.04M in Q2 2023.
  • 342 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2025.

Based on Fox Run Management's 13F filing for Q4 2025, filed 11 Feb 2026.